Journal article
Drug treatments for covid-19: living systematic review and network meta-analysis
Abstract
OBJECTIVE: To compare the effects of treatments for coronavirus disease 2019 (covid-19).
DESIGN: Living systematic review and network meta-analysis.
Authors
Siemieniuk RA; Bartoszko JJ; Zeraatkar D; Kum E; Qasim A; Martinez JPD; Izcovich A; Rochwerg B; Lamontagne F; Han MA
Journal
The BMJ, Vol. 370, ,
Publisher
BMJ
DOI
10.1136/bmj.m2980
ISSN
0959-8138
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
HumansAdenosine MonophosphateAlanineAntiviral AgentsBetacoronavirusCenters for Disease Control and Prevention, U.S.ChinaCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentDatabases, FactualDrug CombinationsEvidence-Based MedicineGlucocorticoidsHydroxychloroquineLopinavirPandemicsPneumonia, ViralRandomized Controlled Trials as TopicRespiration, ArtificialRitonavirSARS-CoV-2Severity of Illness IndexStandard of CareTreatment OutcomeUnited States